Concord Medical Services Holdings Limited

119 articles about Concord Medical Services Holdings Limited

  • Concord Medical Services Holdings Limited announced that it has received a letter from the New York Stock Exchange dated February 12, 2024, notifying the Company that it is below compliance standards due to the trading price of the Company's American depositary shares and that the applicable cure period for the Company to regain compliance expires on August 12, 2024.

  • Concord Medical Services Holdings Limited today announced that it will hold its 2022 annual general meeting of shareholders (the "Meeting") on December 30, 2022, at 10:00 a.m. (Beijing Time).

  • Concord Medical Services Holdings Limited announced the successful holding of the Second Annual Academic Meeting jointly by Shanghai Concord Cancer Center and The University of Texas MD Anderson Cancer Center on November 11 and November 12, 2022.

  • Concord Medical Services Holdings Limited today announced its unaudited consolidated financial results for the six months ended June 30, 2021[1].

  • Concord Medical Services Holdings Limited, a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, announced that as of May 25, 2021, it is late in filing its annual report on Form 20-F for the fiscal year ended December 31, 2020 with the Securities and Exchange Commission.

  • Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China , today announced changes in its board of directors.

  • Concord Medical Services Holdings Limited announced that the Company has, through its subsidiaries, entered into a definitive agreement to sell 90% equity interest in Concord Healthcare Singapore Pte Ltd, which operates and owns a general medical and surgical hospital, namely Concord International Hospital, for a total consideration of approximately SG$52.2 million.

  • Concord Medical Services Holdings Limited, a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, announced that it will hold its 2020 annual general meeting of shareholders on December 21, 2020, at 10:00 a.m.

  •  Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced its Guangzhou

  • Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, today announced that the topp

  • Concord Medical Services Holdings Limited, a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, announced its unaudited consolidated financial results for the six months ended June 30, 2020

  • Concord Medical Services Holdings Limited announced that CITIC Industrial Investment Group Limited, a renowned investment institution, will make an investment in Concord Medical's subsidiary, Meizhong Jiahe Hospital Management Group Co., Ltd., subject to the satisfaction of closing conditions pursuant to an agreement entered into between the parties.

  • Concord Medical Services Holdings Limited, a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers in China, announced the resignation of Mr. Shang Yan Chuang as director of the Company.

  • Concord Medical Services Holdings Limited, a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers in China, announced that it will hold its 2019 annual general meeting of shareholders on December 27, 2019, at 10:00 a.m.

  • Concord Medical Services Holdings Limited announced that Shanghai Concord Medical Cancer Center has become a designated hospital in Shanghai, allowing the general outpatient services and the major outpatient services to be settled by medical insurance according to the standard of the local third-level hospitals.

  • Concord Medical Services Holdings Limited, a leading specialty hospital management solutions provider and an operator of the network of radiotherapy and diagnostic imaging centers in China, announced that it will hold an online Q&A session on June 25, 2019 from 2:00PM to 3:00PM, Beijing Time.

  • Concord Medical Services Holdings Limited announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2018 with the U.S. Securities and Exchange Commission.

  • Concord Medical Services Holdings Limited, a leading specialty hospital management solutions provider and an operator of the largest network of radiotherapy and diagnostic imaging centers in China, announced three new appointments to the management team.

  • Concord Medical Services Holdings Limited announced the nuclear magnetic resonance imaging and cancer radiotherapy services of its Shanghai Concord Medical Cancer Center have been covered by medical insurance from February 20, 2019.

  • Concord Medical Services Holdings Limited, announced a topping out ceremony of Guangzhou Concord Cancer Center has been held at the construction site of the project.